The US Bankruptcy Court approved the combined hearing on an interim basis to consider approval of disclosure statement and plan of Allena Pharmaceuticals, Inc on April 12, 2023. The debtor had filed its disclosure statement and prepackaged plan in the Court on March 17, 2023. The voting record date is April 11, 2023.

The deadline to vote on the plan is May 11, 2023. Any objections to the plan should be made before May 11, 2023 and the confirmation hearing for the plan and disclosure statement has been scheduled for May 18, 2023.